DMAA
Drugs Made In·NASDAQ
--
--(--)
--
--(--)
5.92 / 10
Netural
The fund flow profile scores 5.92/10, demonstrating mixed fund flow signals. Favorable overall, block, Medium, and Extra-large movements are tempered by challenging Small and Large dynamics, supporting neutral flow assessment.
Fund Flow Rating
What is the market sentiment for DMAA?
- DMAA holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.92/10 (Netural).
